| Literature DB >> 31823309 |
Cora Koch1,2, Nadine Dreimüller1, Janosch Weißkircher1, Nicole Deis3, Eva Gaitzsch3, Stefanie Wagner1, Marlene Stoll1, Franziska Bäßler4, Klaus Lieb1, Jana Jünger5.
Abstract
BACKGROUND: Risk communication is a core aspect of a physician's work and a fundamental prerequisite for successful shared decision-making. However, many physicians are not able to adequately communicate risks to patients due to a lack of understanding of statistics as well as inadequate management of conflicts of interest (COI).Entities:
Keywords: Conflict of interest; Medical education; Risk communication; Shared decision-making
Mesh:
Year: 2019 PMID: 31823309 PMCID: PMC7018798 DOI: 10.1007/s11606-019-05420-w
Source DB: PubMed Journal: J Gen Intern Med ISSN: 0884-8734 Impact factor: 5.128
Figure 1Recruitment of participants.
Risk Communication Performance
| Parameter | Baseline | Post-test | Δ (post-test) | Follow-up | Δ (follow-up) |
|---|---|---|---|---|---|
| Risk communication performance | |||||
| Intervention group mean (SD) | 48.36 (7.51) | 70.07 (11.8) | 21.71 (10.24) | 68.46 (10.67) | 19.96 (10.46) |
| Control group mean (SD) | 49.65 (8.12) | 50.74 (7.23) | 0.98 (6.81) | 52.26 (5.59) | 3.14 (7.12) |
| Difference between intervention and control (95% CI; | - | - | 20.73 (15.9 to 25.56; < 0.001) | - | 16.82 (11.49 to 22.16; < 0.001) |
| Cohen’s | - | - | 2.35 (1.62 to 3.01) | - | 1.83 (1.13 to 2.47) |
| Risk communication process | |||||
| Intervention group mean (SD) | 44.76 (5.49) | 49.34 (5.70) | 4.59 (5.83) | 50.39 (4.13) | 5.43 (6.91) |
| Control group mean (SD) | 44.71 (6.77) | 45.26 (5.74) | 0.44 (5.41) | 46.31 (3.98) | 1.45 (5.03) |
| Difference between intervention and control means (95% CI; | - | - | 4.15 (1.06 to 7.24; 0.01) | - | 3.98 (0.39 to 7.57; 0.03) |
| Cohen’s | - | - | 0.74 (0.17 to 1.28) | - | 0.64 (0.05 to 1.21) |
| Risk communication content | |||||
| Intervention group mean (SD) | 3.60 (2.05) | 20.73 (8.44) | 17.12 (7.70) | 18.07 (9.10) | 14.54 (8.34) |
| Control group mean (SD) | 4.94 (4.54) | 5.48 (4.20) | 0.54 (3.27) | 5.95 (3.38) | 1.69 (4.33) |
| Difference between intervention and control means (95% CI; | - | - | 16.58 (13.25 to 19.91; < 0.001) | - | 12.85 (8.83 to 16.86; < 0.001) |
| Cohen’s | - | - | 2.73 (1.95 to 3.43) | - | 1.86 (1.14 to 2.50) |
Δ (post-test), difference between post-test and baseline; Δ (follow-up), difference between follow-up and baseline; intervention group n at baseline 29, post-test 29, follow-up 28; control group n at baseline 26, post-test 25, follow-up 21
Secondary Outcomes—Overview
| Baseline | Post-test | Δ (post-test) | Follow-up | Δ (follow-up) | |
|---|---|---|---|---|---|
| Knowledge (multiple choice questionnaire) | |||||
| Intervention group mean (SD) | 16.63 (3.30) | 24.00 (3.92) | 7.52 (3.04) | 20.93 (3.51) | 4.46 (2.33) |
| Control group mean (SD) | 16.35 (4.29) | 17.93 (3.62) | 1.96 (2.33) | 18.38 (4.15) | 2.08 (2.92)* |
| Difference intervention and control means (95% CI; | - | - | 5.55 (4.09–7.01; < 0.001) | - | 2.38 (0.92–3.84; < 0.001) |
| Cohen’s | - | - | 2.04 (1.37–2.65) | - | 0.91 (0.32–1.47) |
| Skepticism (attitude questionnaire) | |||||
| Intervention group mean (SD) | 0.59 (0.17) | 0.76 (0.14) | 0.19 (0.17) | 0.76 (0.17) | 0.19 (0.20)† |
| Control group mean (SD) | 0.51 (0.15) | 0.54 (0.14) | 0.03 (0.10) | 0.54 (0.17) | 0.02 (0.14) |
| Difference intervention and control means (95% CI; | - | - | 0.16 (0.08–0.23; < 0.001) | - | 0.17 (0.07–0.27; < 0.001) |
| Cohen’s | - | - | 1.15 (0.57–1.69) | - | 0.96 (0.38–1.52) |
| Professionalism regarding COI (situational judgment test) | |||||
| Intervention group mean (SD) | 66.22 (14.02) | 84.48 (16.00) | 18.66 (12.06) | 85.28 (17.11) | 19.12 (15.75)‡ |
| Control group mean (SD) | 55.61 (15.06) | 55.96 (16.55) | 0.27 (7.75) | 60.04 (21.76) | 3.35 (12.94)§ |
| Difference intervention and control means (95% CI; | - | - | 18.39 (12.83–23.94; < 0.001) | - | 15.77 (7.36–24.19; < 0.001) |
| Cohen’s d (95% CI) | - | - | 1.79 (1.14–2.39) | - | 1.09 (0.47–1.68) |
Δ (post-test), difference between post-test and baseline; Δ (follow-up), difference between follow-up and baseline; intervention group n at baseline 32, post-test 29, follow-up 28; control group n at baseline 31, post-test 27, follow-up 25; *n = 24, †n = 27, ‡n = 25, §n = 23
Figure 2Risk communication performance (error bars denote standard deviation).
Relevant Individual Item Data for Attitudes on COI (on a Likert Scale from 0 to 3; Scaled so that a higher score signals a more skeptical attitude)
| Item | Baseline | Post | Δ post | Follow-up | Δ follow-up | |||
|---|---|---|---|---|---|---|---|---|
| Materials from a pharmaceutical company are helpful to inform oneself about new drugs. | Int | 1.63 (0.71) | 2.38 (0.56) | 0.79 (0.78) | < 0.01 | 2.26 (0.71) | 0.70 (0.87) | < 0.01 |
| Con | 1.52 (0.72) | 1.33 (0.55) | − 0.26 (0.90) | 0.15 | 1.20 (0.71) | − 0.48 (0.77) | < 0.01 | |
| Diff. between Int and Con | - | - | 1.05 | < 0.01 | - | 1.18 | < 0.01 | |
| Most CME events or grand rounds sponsored by pharmaceutical companies are helpful and informative. | Int | 1.75 (0.67) | 2.17 (0.60) | 0.45 (0.74) | < 0.01 | 1.96 (0.65) | 0.30 (0.82) | 0.073 |
| Con | 1.19 (0.60) | 1.30 (0.47) | 0.15 (0.66) | 0.26 | 1.44 (0.77) | 0.28 (0.79) | 0.09 | |
| Diff. between Int and Con | - | - | 0.3 | 0.12 | - | 0.016 | 0.94 | |
| CME events or grand rounds sponsored by pharmaceutical companies are usually biased in favor of the company’s product. | Int | 2.56 (0.50) | 2.83 (0.38) | 0.24 (0.69) | 0.07 | 2.65 (0.75) | 0.08 (0.80) | 0.63 |
| Con | 2.42 (0.67) | 2.56 (0.51) | 0.15 (0.60) | 0.21 | 2.48 (0.59) | 0.08 (0.70) | 0.57 | |
| Diff. between Int and Con | - | - | 0.093 | 0.59 | - | 0 | 0.99 | |
| It is sometimes acceptable for medical students to accept gifts or lunch from pharmaceutical companies because pharmaceutical companies have minimal influence on students. | Int | 2.09 (0.86) | 2.45 (0.74) | 0.41 (0.82) | 0.01 | 2.56 (0.58) | 0.59 (0.84) | < 0.01 |
| Con | 1.81 (1.08) | 1.74 (0.90) | − 0.11 (0.97) | 0.56 | 1.92 (0.78) | 0.08 (1.01) | 0.60 | |
| Diff. between Int and Con | - | - | 0.52 | 0.03 | - | 0.51 | 0.057 | |
Int intervention group, Con control group, Δ change within group from baseline
Bias Blind Spot
| Baseline | Post-test | Follow-up | |
|---|---|---|---|
| Intervention group, | 32 | 29 | 26 |
| Influence on me* | 14 (43.8%) | 23 (79.3%) | 24 (92.3%) |
| Influence on others† | 21 (65.6%) | 25 (86.2%) | 24 (92.3%) |
| 0.039 | 0.5 | 1 | |
| Control group, | 31 | 27 | 25 |
| Influence on me* | 12 (38.7%) | 14 (51.9%) | 14 (56.0%) |
| Influence on others† | 21 (67.7%) | 20 (74.1%) | 19 (760%) |
| 0.004 | 0.031 | 0.13 |
*Agreement with the statement “Accepting gifts or food from a drug rep increases the likelihood that I will later prescribe the drugs of that company”
†Agreement with the statement “Accepting gifts or food from a drug rep increases the likelihood that my fellow students will later prescribe the drugs of that company”